Advanced Search

 

Study ID Status Title Patient Level Data
111314 Completed A First-Time-In-Human, Three-Part, Placebo-Controlled, Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK1521498 in Healthy Subjects Study Listed on ClinicalStudyDataRequest.com
111315 Completed Safety and immunogenicity of GSK Biologicals’ candidate malaria vaccine 257049 when administered on different schedules to infants in Africa
111319 Terminated A Single-Blind, Placebo-Controlled, Randomized First Time in Human Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Repeat Dose Escalation of GSK932121 in Healthy Adult Subjects Study Listed on ClinicalStudyDataRequest.com
111321 Completed A single-blind, randomised, placebo-controlled, ascending dose study to evaluate the safety, tolerability and pharmacokinetics of GSK1144814 in healthy male and female subjects and an open-label positron emission tomography study in healthy male subjects to evaluate the neurokinin-1 (NK1) receptor occupancy of GSK1144814 in the living human brain using 11C GR205171.
111330 Completed A Single and Repeat Dose Escalation Study of the Safety, Pharmacokinetics and Pharmacodynamics of GSK1223249 in ALS Patients
111336 Completed An observational, epidemiological study on the prevalence of human papillomavirus (HPV) types in women 15 years of age or older, in the Kingdom of Saudi Arabia
111337 Completed Identification and Characterization of the Bacteria Causing Acute Otitis Media (AOM) Episodes in Young Children in Saudi Arabia
111339 Withdrawn Identification and characterization of the bacteria causing Acute Otitis Media (AOM) episodes in young children in Turkey
111341 Completed A Double-Blind, Parallel, Randomized, Placebo-Controlled, Single Dose Escalation First Time in Human Study to Investigate the Safety, Tolerability and Pharmacokinetics of Investigational Study Drug in Healthy Subjects Study Listed on ClinicalStudyDataRequest.com
111344 Completed Immunogenicity and reactogenicity of GSK Biologicals' DTPa-HBV-IPV/Hib vaccine when given as a booster dose Study Listed on ClinicalStudyDataRequest.com
111345 (Mth 12) Completed Long-term follow-up study to assess antibody persistence in children previously vaccinated with four doses of pneumococcal conjugate vaccine in primary vaccination study (105553) and booster vaccination study (107046) Study Listed on ClinicalStudyDataRequest.com
111364 Completed A 28-Day, Polysomnographic and Subjective Assessment of Vestipitant (15mg/day) for the Treatment of Primary Insomnia in Adult Outpatients Study Listed on ClinicalStudyDataRequest.com
111375 Completed Follow-up study to evaluate the long-term immunogenicity and safety of a HPV vaccine (GSK 580299) in healthy female subjects Study Listed on ClinicalStudyDataRequest.com
111381 Completed Study MPX111381: A dose-ranging study evaluating the efficacy, safety and tolerability of GSK1838262 (XP13512) in the prophylactic treatment of migraine headache
111383 Completed A First-Time-in-Human Randomised, Single Blind Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics, of Single Escalating Doses of GSK1482160, in Male and Female Healthy Subjects, and to make a preliminary assessment of the effect of food. Study Listed on ClinicalStudyDataRequest.com
111393 Completed Immunogenicity & safety study of GSK Biologicals’ meningococcal vaccine GSK134612 when co-administered with GSK Biologicals’ pneumococcal vaccine GSK1024850A in healthy 12-23-month-old children previously primed with GSK1024850A Study Listed on ClinicalStudyDataRequest.com
111405 Completed A Phase I, open label, randomized, two period, one-way two sequence crossover study to evaluate the effect of darunavir/ritonavir and lopinavir/ritonavir on GSK1349572 pharmacokinetics in healthy adult subjects (ING111405).
111406 Completed A First Time In Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GSK1399686 after Single and Repeated Oral Dosing in Healthy Volunteers Using a Dose-Escalating, Randomized, Placebo-Controlled Study Design Study Listed on ClinicalStudyDataRequest.com
111407 Completed A Double-Blind, Double-Dummy, Placebo- and Active-Controlled Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Anti-Inflammatory Effects of GSK1399686 in Patients with Mild to Moderately Active Ulcerative Colitis Study Listed on ClinicalStudyDataRequest.com
111412 Completed An open label, multi-centre, non-interventional post-marketing surveillance to monitor the safety of BONVIVA(Ibandronate) injection administered in Korean patients according to the prescribing information
111413 Completed Evaluation of GSK Biologicals’ Boostrix® vaccine when compared with Decavac™ in adults aged 65 years or older. Study Listed on ClinicalStudyDataRequest.com
111414 Completed Non-inferiority of GSK Biologicals’ meningococcal vaccine (GSK134612) compared to licensed MenC-CRM197 conjugate vaccine in healthy children Study Listed on ClinicalStudyDataRequest.com
111418 Completed An International, Multicentre, Randomised, Open, Controlled, Two-parallel Group, Phase II Pilot Study to Evaluate the Efficacy and Safety of ARIXTRA™ for Anticoagulation of Patients with Atrial Fibrillation undergoing Electric Cardioversion Following Transesophageal Echocardiography
111426 Completed Case-control Study to Evaluate the Vaccine Effectiveness of GlaxoSmithKline (GSK) Biologicals' Live Attenuated Human Rotavirus (HRV) Vaccine (Rotarix™) Against Community-acquired Rotavirus Severe Gastroenteritis (RV SGE) Among Hospitalised Children Born After 1 October 2006, in Belgium
111433 Completed Clinical Evaluation of eltrombopag in Chronic Idiopathic Thrombocytopenic Purpura (ITP)-An extension study of eltrombopag in subjects, with idiopathic thrombocytopenic purpura (ITP), previously enrolled in an eltrombopag study TRA108109 (NCT00540423)-<Phase III Study>

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.